The MBRS-RISE program at AUS will focus on training MS students and facilitate their entry into these PhD programs. This program will fill the gap that exists at ASU to increase the total number of ASU graduates entering PhD programs at major US institutions. The MBRS-RISE program will support five (5) MS students at ASU during years 1-4 and ten (10) MS students in year 5. Each student will be supported for a maximum of two years. In addition to academic year, all RISE students will be provided an opportunity to work in an external collaborator's lab. A team of 7 faculty mentors at ASU will provide research training to RISE students leading into a MS thesis. The research training will be complemented with mentoring by 7 external collaborators resulting in transition of ASU MS graduates into PhD programs at research-intensive institutions. A total of 20 students will be supported in five-year period with 14 entering into PhD programs in biomedical or behavioral sciences.

Public Health Relevance

Alabama State University is applying for an MBRS-RISE Option II proposal to increase the number of underrepresented minority students (URM) enrolling in PhD degrees in biomedical and behavioral sciences.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Education Projects (R25)
Project #
5R25GM106995-02
Application #
8721981
Study Section
(TWD)
Program Officer
Broughton, Robin Shepard
Project Start
2013-09-01
Project End
2018-05-30
Budget Start
2014-06-01
Budget End
2015-05-31
Support Year
2
Fiscal Year
2014
Total Cost
Indirect Cost
Name
Alabama State University
Department
Miscellaneous
Type
University-Wide
DUNS #
City
Montgomery
State
AL
Country
United States
Zip Code
36104
Ashmore, D'Andrea; Chaudhari, Atul; Barlow, Brandi et al. (2018) Evaluation of E. coli inhibition by plain and polymer-coated silver nanoparticles. Rev Inst Med Trop Sao Paulo 60:e18
Dixit, Saurabh; Sahu, Rajnish; Verma, Richa et al. (2018) Caveolin-mediated endocytosis of the Chlamydia M278 outer membrane peptide encapsulated in poly(lactic acid)-Poly(ethylene glycol) nanoparticles by mouse primary dendritic cells enhances specific immune effectors mediated by MHC class II and CD4+ T cells. Biomaterials 159:130-145
Verma, Richa; Sahu, Rajnish; Dixit, Saurabh et al. (2018) The Chlamydia M278 Major Outer Membrane Peptide Encapsulated in the Poly(lactic acid)-Poly(ethylene glycol) Nanoparticulate Self-Adjuvanting Delivery System Protects Mice Against a Chlamydia muridarum Genital Tract Challenge by Stimulating Robust Systemic Front Immunol 9:2369
Duncan, Skyla A; Baganizi, Dieudonné R; Sahu, Rajnish et al. (2017) SOCS Proteins as Regulators of Inflammatory Responses Induced by Bacterial Infections: A Review. Front Microbiol 8:2431
Eroglu, Erdal; Singh, Ankur; Bawage, Swapnil et al. (2016) Immunogenicity of RSV F DNA Vaccine in BALB/c Mice. Adv Virol 2016:7971847
Valdez, Jesus; Bawage, Swapnil; Gomez, Idalia et al. (2016) Facile and rapid detection of respiratory syncytial virus using metallic nanoparticles. J Nanobiotechnology 14:13
Chaudhari, Atul A; Ashmore, D'andrea; Nath, Subrata Deb et al. (2016) A novel covalent approach to bio-conjugate silver coated single walled carbon nanotubes with antimicrobial peptide. J Nanobiotechnology 14:58
Chaudhari, Atul A; Vig, Komal; Baganizi, Dieudonné Radé et al. (2016) Future Prospects for Scaffolding Methods and Biomaterials in Skin Tissue Engineering: A Review. Int J Mol Sci 17:
Dosunmu, Ejovwoke F; Chaudhari, Atul A; Bawage, Swapnil et al. (2016) Novel cationic peptide TP359 down-regulates the expression of outer membrane biogenesis genes in Pseudomonas aeruginosa: a potential TP359 anti-microbial mechanism. BMC Microbiol 16:192
Coats, Mamie T (2016) Combating Malaria: Where do We Stand? J Infect Dis Ther 4:

Showing the most recent 10 out of 24 publications